Top Markets
Coin of the day
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
株式のランク #13241
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
株価
$4.99
時価総額
$508.03M
変化(1日)
-2.48%
変化(1年)
2.10%
TW
取引 Ever Supreme Bio Technology Co., Ltd (6712)

カテゴリー

Ever Supreme Bio Technology Co., Ltd(6712)の配当利回りの履歴
Ever Supreme Bio Technology Co., Ltd(銘柄コード: 6712)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Ever Supreme Bio Technology Co., Ltd(6712)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)